Novacyt completes €2m private placement to support second half sales growth

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, reported earlier its strong first-half sales performance across the Group and the completion of €3.5m in bond refinancing. Today, Novacyt is pleased to announce a further private placement financing of €2m.

Download press release